Vivanza Biosciences Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 178.07 million compared to INR 104 million a year ago. Revenue was INR 182.82 million compared to INR 112.29 million a year ago.

Net income was INR 5.98 million compared to INR 3.33 million a year ago. Basic earnings per share from continuing operations was INR 0.15 compared to INR 0.083 a year ago. Diluted earnings per share from continuing operations was INR 0.15 compared to INR 0.083 a year ago.